← Open Payments lookup

MARK WRIGHT: Open Payments

NPI 1154448991 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$160,591 in 208 payments from 18 companies in 2025. Trend: 2023 $111,255 · 2024 $146,066 · 2025 $160,591

Honoraria: $89,500Speaker / faculty: $45,859Consulting: $10,080Travel & lodging: $8,685Food & beverage: $3,875Speaker / faculty: $2,363
CompanyPaymentsAmount
Axsome Therapeutics, Inc.64$67,245
Neurocrine BioSciences, Inc.23$28,651
Supernus Pharmaceuticals, Inc.38$21,580
Alkermes, Inc.17$17,485
Teva Pharmaceuticals USA, Inc.9$13,994
Tris Pharma Inc14$8,316
Noven Therapeutics, LLC10$2,632
Corium, LLC8$146
Collegium Pharmaceutical, Inc.6$118
Otsuka America Pharmaceutical, Inc.4$93

Products named: Auvelity, INGREZZA, Qelbree, LYBALVI, AUSTEDO XR, Dyanavel XR, Xelstrym, REXULTI.

Industry payments across KY — which companies pay providers there.